GAF Healthcare
Обзор направления

Лучшие больницы для «Breast Reduction Surgery» в Мумбаи, Индия

17 больниц по направлению «Дерматология» представлены в нашей сети в Индия, Мумбаи, с аккредитацией JCI, NABH, NABL, ISO 9001.

17
больниц в списке
1
город
4.6
средний рейтинг
4
вида аккредитации
Короткий ответ

На этой странице перечислены больницы направления «Дерматология» (включая Breast Reduction Surgery) в Мумбаи, Индия, включая Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai и другие.

Спросите нас о «Breast Reduction Surgery» в Мумбаи, Индия

Оставьте свои данные — наша команда координации свяжется с вами и расскажет о следующих шагах.

Сравните 17 аккредитованных больниц (Дерматология) в Мумбаи, Индия

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 отзывов) 350 коек

Больница занимает 1-е место в этом списке по указанному рейтингу (5/5, 12 отзывов).

Почему стоит выбрать эту больницу?
Рейтинг 5 из 5 (12 отзывов)Аккредитация: JCI, NABH350 коек
Специализации и аккредитация
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
Аккредитация JCI, NABH
5/5
Рейтинг
1950
Основана в
350
Койки
Mumbai, India
Расположение
#2
Kokilaben Dhirubhai Ambani Hospital

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 отзывов) 750 коек

Больница занимает 2-е место в этом списке по указанному рейтингу (4.8/5, 1800 отзывов).

Почему стоит выбрать эту больницу?
Рейтинг 4.8 из 5 (1800 отзывов)Аккредитация: JCI, NABH750 коек
Специализации и аккредитация
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Аккредитация JCI, NABH
4.8/5
Рейтинг
2009
Основана в
750
Койки
Mumbai, India
Расположение
#3
Tata Memorial Hospital

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 отзывов) 629 коек

Больница занимает 3-е место в этом списке по указанному рейтингу (4.8/5, 2500 отзывов).

Почему стоит выбрать эту больницу?
Рейтинг 4.8 из 5 (2500 отзывов)Аккредитация: NABH629 коек
Специализации и аккредитация
OncologyCancer Center
Аккредитация NABH
4.8/5
Рейтинг
1941
Основана в
629
Койки
Mumbai, India
Расположение
#4
Apollo Hospitals, Navi Mumbai

🇮🇳 Apollo Hospitals, Navi Mumbai

Mumbai, India 4.8 (512 отзывов) 500 коек

Больница занимает 4-е место в этом списке по указанному рейтингу (4.8/5, 512 отзывов).

Почему стоит выбрать эту больницу?
Рейтинг 4.8 из 5 (512 отзывов)Аккредитация: JCI, NABH500 коек
Специализации и аккредитация
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Аккредитация JCI, NABH
4.8/5
Рейтинг
2016
Основана в
500
Койки
Mumbai, India
Расположение
#5
Gleneagles Hospital, Mumbai

🇮🇳 Gleneagles Hospital, Mumbai

Mumbai, India 4.8 (615 отзывов) 638 коек

Больница занимает 5-е место в этом списке по указанному рейтингу (4.8/5, 615 отзывов).

Почему стоит выбрать эту больницу?
Рейтинг 4.8 из 5 (615 отзывов)Аккредитация: JCI, NABH638 коек
Специализации и аккредитация
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Аккредитация JCI, NABH
4.8/5
Рейтинг
2008
Основана в
638
Койки
Mumbai, India
Расположение
#6
Lilavati Hospital And Research Centre

🇮🇳 Lilavati Hospital And Research Centre

Mumbai, India 4.8 (724 отзывов) 326 коек

Больница занимает 6-е место в этом списке по указанному рейтингу (4.8/5, 724 отзывов).

Почему стоит выбрать эту больницу?
Рейтинг 4.8 из 5 (724 отзывов)Аккредитация: JCI, NABH326 коек
Специализации и аккредитация
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Аккредитация JCI, NABH
4.8/5
Рейтинг
1997
Основана в
326
Койки
Mumbai, India
Расположение
#7
Jaslok Hospital

🇮🇳 Jaslok Hospital

Mumbai, India 4.6 (129 отзывов) 350 коек

Больница занимает 7-е место в этом списке по указанному рейтингу (4.6/5, 129 отзывов).

Почему стоит выбрать эту больницу?
Рейтинг 4.6 из 5 (129 отзывов)Аккредитация: NABH, NABL350 коек
Специализации и аккредитация
Cardiac SurgeryNeurosciencesOncologyOrthopedicsTransplant
Аккредитация NABH, NABL
4.6/5
Рейтинг
1973
Основана в
350
Койки
Mumbai, India
Расположение
#8
Gleneagles Global Hospitals (Global Hospitals)

🇮🇳 Gleneagles Global Hospitals (Global Hospitals)

Parel, Mumbai, India 4.6 (183 отзывов) 450 коек

Больница занимает 8-е место в этом списке по указанному рейтингу (4.6/5, 183 отзывов).

Почему стоит выбрать эту больницу?
Рейтинг 4.6 из 5 (183 отзывов)Аккредитация: NABH, JCI450 коек
Специализации и аккредитация
Liver TransplantCardiac SurgeryOrthopedicsOncologyNeurosciences
Аккредитация NABH, JCI
4.6/5
Рейтинг
1996
Основана в
450
Койки
Parel, Mumbai, India
Расположение
#9
Medicover Hospital, Navi Mumbai

🇮🇳 Medicover Hospital, Navi Mumbai

Navi Mumbai, India 4.6 (143 отзывов) 310 коек

Больница занимает 9-е место в этом списке по указанному рейтингу (4.6/5, 143 отзывов).

Почему стоит выбрать эту больницу?
Рейтинг 4.6 из 5 (143 отзывов)Аккредитация: NABH310 коек
Специализации и аккредитация
Cardiac SurgeryCardiologyOncologyOrthopedicsNeurologyGastroenterology
Аккредитация NABH
4.6/5
Рейтинг
2023
Основана в
310
Койки
Navi Mumbai, India
Расположение
#10
KIMS Hospitals, Thane

🇮🇳 KIMS Hospitals, Thane

Mumbai, India 4.6 (58 отзывов) 300 коек

Больница занимает 10-е место в этом списке по указанному рейтингу (4.6/5, 58 отзывов).

Почему стоит выбрать эту больницу?
Рейтинг 4.6 из 5 (58 отзывов)Аккредитация: NABH300 коек
Специализации и аккредитация
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Аккредитация NABH
4.6/5
Рейтинг
2025
Основана в
300
Койки
Mumbai, India
Расположение
Наша методология

Как мы выбираем эти больницы

Больница появляется на этой странице, если направление «Дерматология» указано среди её специализаций и она находится в Мумбаи, Индия. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».

На что обратить внимание

Как выбрать лучшую больницу для «breast reduction surgery» в Мумбаи, Индия?

Выбор подходящей больницы для «breast reduction surgery» — важное решение в вашем пути лечения. Вот на что стоит обратить внимание:

Международная аккредитация

Ищите больницу с международной аккредитацией, например JCI или NABH — см. отметки аккредитации у каждой больницы ниже.

Специализация

Убедитесь, что в больнице есть отделение, специализирующееся на «Дерматология», а не только общая помощь.

Мощность и опыт

Количество коек и год основания, указанные ниже, отражают масштаб и операционный опыт больницы.

Прозрачность стоимости

Запросите детализированную смету перед поездкой — используйте наш калькулятор стоимости для первичной оценки.

Клинический обзор

Что нужно знать о процедуре «Breast Reduction Surgery»

Breast reduction surgery (reduction mammaplasty) is a well-established surgical procedure that removes excess glandular tissue, fat, and skin to achieve a breast size proportionate to the patient's body, reliably alleviating chronic pain, postural deformity, and psychosocial distress caused by macromastia. In experienced hands at accredited centres, the procedure carries a clinical success rate exceeding 95% for symptomatic relief and patient-reported satisfaction. GAF Healthcare connects international patients with board-certified plastic surgeons at JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed facilities in Dubai and Abu Dhabi, delivering world-class outcomes at highly competitive costs with end-to-end concierge support. Hospital Stay: 1–2 days • Total Stay in Country (Fit-to-Fly): 2–3 weeks • Success Rate: 95–97%

Clinical Overview
Who is a Candidate?
Treatment Options & Approaches
Восстановление

Clinical Overview

Macromastia — pathologically enlarged breasts — is a recognised medical condition that imposes multisystem physiological burden. Mechanically, the excess weight (which can range from 500 g to more than 2,000 g of tissue per breast) creates a chronic forward-flexion load on the cervical and thoracic spine, contributing to trapezius myofascial pain, interscapular nerve entrapment, cervicogenic headaches, and accelerated degenerative disc disease. Dermatologically, chronic skin-on-skin maceration beneath the inframammary fold produces recurrent intertrigo, candidal infections, and contact dermatitis. Respiratorily, large ptotic breasts restrict thoracic excursion, worsening obstructive sleep apnoea and exercise-induced dyspnoea. Psychosocially, macromastia is strongly linked to body-image disorder, social anxiety, and clinical depression, all quantifiable through validated instruments such as the BREAST-Q and the Multidimensional Body-Self Relations Questionnaire (MBSRQ). The physiological mechanism driving symptomatic macromastia involves disproportionate expansion of glandular stroma and adipose tissue, often exacerbated by hormonal fluctuations (puberty, pregnancy, exogenous oestrogen), obesity, and, in rare cases, juvenile gigantomastia driven by progesterone receptor hypersensitivity. Hypertrophic breast tissue is not merely cosmetic excess; it alters chest-wall kinematics and shoulder girdle biomechanics in ways measurable by surface electromyography and gait analysis. The global standard of care for symptomatic macromastia is reduction mammaplasty, a procedure that has been refined over more than a century. Modern evidence-based practice, reflected in guidelines from the American Society of Plastic Surgeons (ASPS) and the British Association of Aesthetic Plastic Surgeons (BAAPS), requires preoperative documentation of functional impairment, appropriate imaging (mammography or ultrasound in women over 35 or with risk factors), and surgeon-specific training in vascular pedicle design to preserve nipple-areola complex (NAC) sensation and lactation potential. In centres of excellence in India and the UAE, these standards are met or exceeded through continuous surgical audit and outcome tracking.

Who is a Candidate?

• Women aged 18 and above (skeletal maturity confirmed) with disproportionately large breasts causing documented functional symptoms (neck/back/shoulder pain, skin rashes, postural deformity, activity limitation) • Patients with a minimum resection volume typically ≥ 500 g per breast (threshold used by most insurance and surgical panels) • Body Mass Index (BMI) ideally ≤ 35 kg/m²; patients with BMI 35–40 may be considered after optimisation; BMI > 40 is a relative contraindication requiring prehabilitation • Non-smokers, or patients who have ceased smoking ≥ 6 weeks preoperatively (smoking raises wound-healing complication risk by 3–5× in skin-flap surgery) • Patients with stable weight (not planning significant further weight loss or pregnancy in the near term, as these events alter outcomes) • Patients with BREAST-Q functional subscale scores indicating clinically significant impairment Required Preoperative Diagnostics: • Full-field digital mammography (FFDM) or breast ultrasound for women ≥ 35 years or with a first-degree family history of breast cancer • MRI breast if inconclusive mammographic findings or BRCA carrier status • Complete blood count (CBC), coagulation profile (PT/INR/aPTT), metabolic panel, HbA1c (for diabetic patients) • Electrocardiogram (ECG) and anaesthesia fitness evaluation • Thrombosis risk stratification using the Caprini Score (DVT prophylaxis planning) • Photographic documentation and 3D surface imaging (Vectra® or similar) for surgical planning Contraindications: • Active or incompletely treated breast malignancy (biopsy-proven; coordinate with oncology) • Uncontrolled diabetes mellitus (HbA1c > 8.0%) — significantly elevates wound breakdown risk • Active collagen vascular disease (e.g., systemic sclerosis) impairing wound healing • Coagulopathies not amenable to peri-operative management • Unrealistic aesthetic expectations not addressable by reduction alone • Patients planning imminent pregnancy (lactation may be affected; counsel and defer when appropriate)

Treatment Options & Approaches

Breast reduction surgery is not a single monolithic operation; the surgeon selects a technique based on breast volume, degree of ptosis (Regnault classification Grades I–III), desired final volume, NAC position, patient body habitus, and the critical need to preserve nipple-areola vascularity and sensory innervation. 1. Inferior Pedicle with Inverted-T (Wise Pattern) Technique — Gold Standard for Large Reductions The most widely performed approach globally, suitable for large to massive macromastia. The NAC is carried on a broad inferior dermoglandular pedicle supplied by the fourth intercostal perforator and the internal mammary artery branches. Resection volumes of 500 g to > 2,500 g per side are reliably achieved. The resultant scar pattern forms an anchor or inverted-T (periareolar + vertical + horizontal inframammary). Long-term outcome data spanning > 30 years confirm durable relief of functional symptoms in > 95% of patients. 2. Vertical (Short-Scar / Lejour / Hall-Findlay) Technique — Preferred for Moderate Macromastia The vertical technique eliminates the horizontal inframammary scar, leaving only a periareolar + vertical scar (lollipop pattern). The superomedial pedicle, popularised by Hall-Findlay, provides excellent NAC perfusion and superior long-term breast shape. Optimal for resection volumes of 300–800 g per breast. Associated with lower revision rates for scar-related complaints and superior patient satisfaction on BREAST-Q aesthetics subscale in randomised trials. 3. Superomedial Pedicle with Wise Pattern — Versatile Hybrid Combines the reliable perfusion of the superomedial pedicle with the skin-pattern versatility of the Wise pattern. Increasingly preferred by high-volume surgeons for moderate-to-large reductions requiring precise NAC repositioning > 10 cm. 4. Free Nipple Graft (FNG) Technique — For Severe Ptosis or Very Large Resections Indicated when the NAC must be relocated > 15–20 cm or when pedicle length would compromise perfusion (e.g., very large breasts, BMI > 35). The NAC is detached, resized, and grafted back as a full-thickness skin graft. Trade-off: complete loss of nipple sensation and lactation capacity. Reserved for carefully counselled patients where safety and resection volume are prioritised over function. 5. Liposuction-Assisted Reduction / Pure Liposuction Reduction For patients with predominantly fatty macromastia (confirmed by ultrasound/MRI showing > 60–70% adipose content) without significant ptosis. VASER® ultrasound-assisted liposuction or power-assisted liposuction (PAL) can reduce breast volume by 300–600 cc per side with minimal scarring. Not appropriate where significant skin excess and ptosis coexist. Increasingly combined with the above open techniques to sculpt lateral breast rolls. 6. Robotic and Endoscopic Assistance Emerging in tertiary centres in India and the UAE: endoscopic visualisation and robotic-arm assistance (da Vinci® platform in selected centres) are being evaluated to improve haemostasis and reduce intraoperative blood loss in complex reductions, though open techniques remain the primary standard of care for this procedure. 7. Simultaneous Procedures Mastoscopy (intraoperative endoscopic evaluation of breast ducts), concurrent axillary lymph node assessment, and incidental benign lesion excision can be performed at the same sitting. All resected tissue is sent for routine histopathological examination — this has resulted in incidental detection of occult carcinoma in 0.06–4% of cases across published series, reinforcing the oncological value of the procedure.

Восстановление

PRE-OPERATIVE PHASE (4–6 Weeks Before Surgery) • GAF Healthcare facilitates remote video consultation with the chosen plastic surgeon; 3D imaging files and medical records are reviewed electronically. • Completion of mandatory diagnostics: mammography/ultrasound, blood panel, ECG, anaesthesia clearance. • Caprini DVT risk score calculated; high-risk patients commence low-molecular-weight heparin (LMWH) perioperatively. • Cessation of NSAIDs, aspirin, vitamin E, and herbal supplements ≥ 2 weeks prior (bleed risk). • Smoking cessation confirmed ≥ 6 weeks preoperatively. • Travel and accommodation arrangements finalised by GAF Healthcare; medical e-visa (India) or entry visa (UAE) processed. • Arrival in country 1–2 days before surgery for in-person consultation, surgical marking, and pre-anaesthesia workup. DAY OF SURGERY • Admission to hospital, pre-operative surgical marking performed by the surgeon in upright position — critical for symmetry. • General anaesthesia administered; duration typically 2.5–4 hours depending on resection volume and technique. • Tumescent infiltration (epinephrine-containing solution) minimises intraoperative blood loss. • Resected tissue weighed and labelled bilaterally; sent for histopathology. • Surgical drains (Jackson-Pratt) placed if resection > 500 g per side. • Compression surgical bra applied in theatre. HOSPITAL STAY (Days 1–2) • Vital monitoring, pain management (multimodal analgesia: paracetamol + NSAIDs + TAP-block or intercostal nerve blocks reduce opioid requirement). • DVT prophylaxis: LMWH injections and pneumatic compression stockings from Day 0. • First drain check and wound inspection on Day 1. • Mobilisation begins Day 1 (gentle ambulation). • Discharge Day 2 with compression bra, drain care instructions, oral antibiotics (5–7 days), and analgesics. EARLY RECOVERY (Weeks 1–3, In-Country) • Drains removed at Day 5–7 when output < 30 ml/24 hours. • First outpatient wound review at Day 7 (suture line inspection, dressing change). • Histopathology results reviewed at Day 7–10 consultation. • Activity restriction: no lifting > 2 kg, no overhead arm movements for 3 weeks. • Compression bra worn 24 hours/day for minimum 6 weeks. • Patients are cleared for international air travel (fit-to-fly) typically at 14–21 days post-surgery, subject to wound integrity and surgeon sign-off. MID RECOVERY (Weeks 3–6) • Return to light desk work at 2–3 weeks. • Driving permitted at 3–4 weeks (when arm movement and reflexes unrestricted). • Scar management initiated: silicone gel sheets or silicone-based creams applied to healed incisions from Week 3 onward; continue for 3–6 months. LONG-TERM RECOVERY (Months 2–6) • Return to full exercise, swimming, and aerobic activity at 6 weeks. • Final breast shape and scar maturation assessed at 3 months and 6 months. • BREAST-Q outcome scores documented at 6 months for audit. • Annual breast screening (mammography or ultrasound) recommended — surgical scarring is documented for radiologist reference to avoid future misinterpretation.

Возможные риски

Breast reduction surgery is among the most patient-satisfying procedures in plastic surgery, but patients must be fully informed of procedure-specific and anaesthesia-related risks before consent. Common and Expected: Temporary swelling, bruising, and altered nipple sensation (dysaesthesia) lasting 6–12 weeks. Surgical scars are permanent, though they fade significantly over 12–18 months; hypertrophic or keloid scarring occurs in 5–10% of patients and is more prevalent in darker Fitzpatrick skin types (relevant for South Asian and Middle Eastern patients). Wound Complications: Wound dehiscence (partial or complete opening) occurs in 5–15% of cases, most commonly at the T-junction of the inverted-T scar. Risk is markedly elevated by smoking, diabetes, and BMI > 35. Minor dehiscences heal by secondary intention; major ones may require revision closure. Infection: Superficial surgical site infection (SSI) rate is approximately 2–5%; deep infection is rare (< 1%). Managed with antibiotics; abscess formation may require drainage. Haematoma and Seroma: Haematoma (blood collection) occurs in 1–3% and may require operative evacuation. Seroma (serous fluid collection) is more common at 5–10% and is managed with serial aspiration. Nipple-Areola Complex (NAC) Complications: Partial NAC necrosis occurs in < 2% of cases with pedicle techniques and is higher (5–10%) with free nipple grafts. Total NAC loss is rare (< 0.5%) but possible in very large reductions or with compromised vascularity. Sensory Changes: Temporary or permanent reduction in nipple sensation affects 10–15% of patients; conversely, hyperaesthesia (painful hypersensitivity) affects a smaller subset. Nerve regeneration continues for up to 12–18 months. Lactation Impact: Pedicle techniques (inferior, superomedial) preserve lactation potential in the majority of patients; however, patients should be counselled that successful breastfeeding cannot be guaranteed post-operatively. Free nipple graft technique eliminates lactation capacity. Thromboembolic Events: Deep vein thrombosis (DVT) and pulmonary embolism (PE) are serious but rare (< 0.5%) when appropriate Caprini-score-guided LMWH prophylaxis and mechanical compression are employed. Anaesthetic Risk: General anaesthesia carries standard systemic risks (cardiac, pulmonary, allergic reaction); pre-anaesthesia evaluation mitigates these. All accredited hospitals in the GAF Healthcare network maintain full intensive care capability. Asymmetry and Revision Surgery: Minor residual asymmetry is common (the human body is inherently asymmetric); significant asymmetry requiring revision occurs in 3–8% of cases. Oncological Consideration: All resected tissue undergoes histopathological examination. Incidental occult breast cancer is identified in published series at rates of 0.06–4.0%, underscoring the importance of this step and of appropriate preoperative mammographic screening.

Почему GAF Healthcare

GAF Healthcare provides structured, end-to-end non-medical support to ensure that the clinical experience is not undermined by logistical complexity. Visa Assistance — India: International patients travelling to India for breast reduction surgery are eligible for the e-Medical Visa, which permits stays of up to 60 days (extendable) and allows one attendant (spouse, family member) on a co-travelling e-Medical Attendant Visa. GAF Healthcare's visa coordination team prepares and reviews the complete application package — hospital invitation letter, treatment plan, passport documents — and guides patients through the online submission portal, targeting visa approval within 3–5 business days. Visa Assistance — UAE (Dubai / Abu Dhabi): Citizens of more than 50 countries receive visa-on-arrival or visa-free entry to the UAE for up to 30–90 days, which is sufficient for the treatment and recovery period. Patients from countries requiring advance visas receive full support from GAF Healthcare's UAE coordination team, including tourist or medical visit visa facilitation through the General Directorate of Residency and Foreigners Affairs (GDRFA). Airport-to-Hospital Transfers: Pre-arranged private vehicle transfers are confirmed for the patient and attendant on arrival, between hospital and accommodation, and for departure — eliminating the stress of navigating unfamiliar cities post-surgery. Dedicated Patient Coordinator: Each patient is assigned a single named GAF Healthcare coordinator who serves as a 24/7 point of contact from the moment of inquiry through discharge and the post-operative follow-up period. The coordinator liaises directly with the surgical team, hospital billing, pharmacy, and accommodation. Medical Translation: Professional medical interpreters are available for Arabic, Russian, French, Swahili, and other languages in both India and UAE destinations, ensuring accurate informed-consent discussions, prescription comprehension, and discharge instruction clarity. Accommodation for Patient and Attendant: GAF Healthcare maintains curated partnerships with serviced apartments and hotels in proximity to partner hospitals — selected for cleanliness standards appropriate for immunocompromised post-surgical patients. Options span economy to luxury tiers. Meal delivery, laundry, and nurse-visit-at-hotel arrangements are available on request. Post-Discharge Teleconsultation: Following return home, patients receive scheduled video follow-up consultations with their surgeon at Day 30, Day 90, and Month 6, with digital wound photo review facilitated through GAF Healthcare's secure patient portal.

Частые вопросы о процедуре «Breast Reduction Surgery»

What is the cost of Breast Reduction Surgery in India compared to the UAE?
In India, breast reduction surgery at a JCI- or NABH-accredited hospital through GAF Healthcare is estimated at USD 2,500–5,000 all-inclusive (surgery, anaesthesia, 1–2 nights hospital stay, histopathology, standard post-operative medications, and outpatient follow-up consultations during the in-country recovery period). In the UAE (Dubai or Abu Dhabi), the equivalent procedure at a JCI- and DHA-licensed facility costs approximately USD 6,000–12,000, reflecting higher facility and operational overheads. India is therefore approximately 50–65% more affordable than the UAE for this procedure. Both destinations provide access to fellowship-trained plastic surgeons, internationally accredited facilities, and identical surgical technique standards. The choice between destinations typically depends on budget, preferred travel distance, and the level of hotel-style hospital amenity desired. GAF Healthcare provides itemised cost breakdowns for both destinations prior to any financial commitment.
How long do I need to stay in the country before I am fit to fly home after Breast Reduction Surgery?
Most patients are cleared for international air travel 14–21 days after breast reduction surgery, subject to individual wound healing progress and formal surgeon sign-off at the final in-country consultation. The specific milestones that must be met before fit-to-fly clearance are: (1) all surgical drains removed (typically by Day 5–7); (2) no active wound infection or significant dehiscence; (3) haematoma and seroma ruled out on clinical examination; (4) histopathology results reviewed; and (5) the patient is independently mobile and comfortable in a seated position for extended periods. Patients should plan for a minimum 2-week stay (approximately 14–17 days for uncomplicated cases) or up to 3 weeks for larger resections or slower wound healing. Compression bra must be worn throughout the flight. GAF Healthcare coordinators schedule and confirm the fit-to-fly consultation with the surgeon and assist with flight rebooking if the recovery timeline extends beyond the original plan.
What is the success rate of Breast Reduction Surgery?
Breast reduction surgery (reduction mammaplasty) is one of the highest patient-satisfaction procedures in all of plastic surgery. Clinical and functional success — defined as significant or complete relief of neck, back, and shoulder pain; resolution of skin rashes; and improvement in activity tolerance — is reported in 95–97% of patients across large published series and validated by BREAST-Q outcome instruments. Aesthetic satisfaction (patient-reported satisfaction with breast appearance, size, and symmetry) rates exceed 90% at 1-year follow-up. Complication rates are low when surgery is performed by a board-certified plastic surgeon at an accredited facility: major complications (haematoma requiring surgery, significant wound breakdown, NAC compromise) occur in fewer than 3–5% of cases. Revision surgery for asymmetry or scar correction is required in approximately 3–8% of patients. Long-term symptomatic recurrence due to weight gain or hormonal changes can occur but is uncommon in weight-stable patients. GAF Healthcare partners exclusively with high-volume surgeons whose individual audit data on complication and revision rates are available for patient review on request.

Как GAF Healthcare помогает выбрать лучшую больницу для «breast reduction surgery» в Мумбаи, Индия

Найдите лучшие больницы для «breast reduction surgery» в Мумбаи, Индия

На этой странице представлено 17 больниц в Мумбаи, Индия, чтобы вы могли сравнить аккредитацию и специализации в одном месте.

Поддержка, когда она нужна

Отправьте нам свои медицинские отчёты в WhatsApp или по email — наша медицинская команда изучит их и предложит больницу и план лечения.

Прозрачные, всё включено цены

Мы предоставляем единую детализированную смету, покрывающую расходы больницы и проживание — без скрытых платежей.

Организация визы, поездки и проживания

После выбора больницы мы помогаем оформить визовое приглашение, забронировать проживание рядом с больницей и организовать трансфер.

Хотите узнать примерную стоимость лечения? Используйте наш калькулятор стоимости для персональной оценки.

Частые вопросы

Частые вопросы о «Breast Reduction Surgery» в Мумбаи, Индия

Сколько больниц направления «Дерматология» представлено в Мумбаи, Индия?
Сейчас в Мумбаи, Индия представлено 17 больниц.
Как вы выбираете больницы для списка?
Больница появляется на этой странице, если направление «Дерматология» указано среди её специализаций и она находится в Мумбаи, Индия. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».
Сколько стоит лечение в Мумбаи, Индия?
Стоимость зависит от больницы, города и конкретного случая. Используйте наш калькулятор стоимости для персональной оценки.
🤔

Остались вопросы?

Наша команда готова ответить на вопросы о «Breast Reduction Surgery» в Мумбаи, Индия.

Следующий шаг

Отправьте нам свои медицинские отчёты — наша команда предложит больницу и план лечения для «Breast Reduction Surgery» в Мумбаи, Индия.

Свяжитесь с нами, если заметите неточность на этой странице.